Related Experiment Video
Updated: Dec 30, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
miR-182 promotes cell proliferation and invasion by inhibiting APC in melanoma
Xilin Liu1, Hong Li2, Guangzhi Wu1
1Department of Hand Surgery, China-Japan Union Hospital of Jilin University Changchun, Jilin Province, China.
Objective:
Common treatment methods have shown a lack of therapeutic effect in melanoma, a type of malignant tumor. The pathogenesis of melanoma is not yet fully clear, therefore, search for a new treatment strategy is urgent. Recent studies have demonstrated that miR-182 is remarkably over-expressed in human melanoma. Our study aimed to explore the underlying mechanism of miR-182 on melanoma.
Methods:
In this study, the expression level of miR-182 was detected using RT-PCR in melanoma and adjacent tissues as well as in HEM-m, A375, A2058, and WM35 cell lines. Functions of miR-182 were investigated by using CCK-8 on cell proliferation, apoptosis, invasion, and cell cycle on A375 cells. Moreover, expression levels of Frz, Dsh, β-catenin, APC, Axin, GSK-3β, and CK1 were detected by Western blotting after knockdown and overexpression of miR-182. Overexpression of miR-182 and knockdown of APC was used to demonstrate regulated functions in melanoma.
Results:
Expression levels of miR-182 were significantly upregulated in melanoma tissues and cell lines. Overexpression of miR-182 promoted cell proliferation, migration, and invasion while inhibiting cell apoptosis and cell cycle in S phase. Overexpression of miR-182 upregulated expression levels of β-catenin and APC. Overexpression of miR-182 and knockdown of APC inhibited proliferation of melanoma cells and tumors.
Conclusion:
Overexpression of miR-182 promotes cell proliferation and invasion by targeting to APC in melanoma. The pathogenesis of miR-182 and APC might provide therapeutic targets for treatment of melanoma in the molecular level.
Insights
MicroRNA-182 (miR-182) is overexpressed in melanoma, promoting cancer cell proliferation and invasion. Targeting miR-182 and APC may offer new therapeutic strategies for melanoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma treatment faces challenges due to limited therapeutic effects.
- The precise pathogenesis of melanoma remains unclear, necessitating novel treatment strategies.
- MicroRNA-182 (miR-182) is significantly overexpressed in human melanoma.
Purpose of the Study:
- To investigate the role and underlying mechanism of miR-182 in melanoma.
- To explore miR-182 as a potential therapeutic target for melanoma.
Main Methods:
- RT-PCR was used to detect miR-182 expression in melanoma tissues and cell lines.
- Cell proliferation, apoptosis, invasion, and cell cycle were assessed using CCK-8 assays.
- Western blotting analyzed protein expression of key molecules in the Wnt/β-catenin pathway.
Main Results:
- miR-182 expression was significantly upregulated in melanoma.
- Overexpression of miR-182 enhanced melanoma cell proliferation, migration, and invasion.
- miR-182 targeted APC, influencing proliferation and tumor growth.
Conclusions:
- Overexpression of miR-182 promotes melanoma cell proliferation and invasion by targeting APC.
- The miR-182 and APC pathway presents a potential therapeutic target for melanoma treatment at the molecular level.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle

